Organization
Azienda Ospedaliero-Universitaria di Parma
2 clinical trials
2 abstracts
Clinical trial
Assessment of Pancreatic Beta Cell Mass and Function With the Aid of Positron Emission Tomography Imaging in Human Diabetes MellitusStatus: Recruiting, Estimated PCD: 2024-10-01
Abstract
A multinational pivotal study of sunvozertinib in platinum pretreated non-small cell lung cancer with EGFR exon 20 insertion mutations: Primary analysis of WU-KONG1 study.Org: Azienda Ospedaliero-Universitaria di Parma, Azienda Ospedaliero Universitaria Policlinico G. Rodolico - San Marco,
Clinical trial
A Prospective, Randomized, Parallel-group, Adaptive Design Phase IIb/III, Multicenter Study, to Assess the Efficacy of Polychemotherapy for Inducing Remission of Newly Diagnosed Type 2 Diabetes.Status: Active (not recruiting), Estimated PCD: 2024-03-02
Abstract
Real-world impact of olaparib use in patients (pts) with advanced pancreatic cancer (PC) harboring germline BRCA1/2 (gBRCA) mutations.Org: University of Verona, Oncology Section, Verona University Hospital Trust (AOUI Verona), IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele Facoltà di Medicina e Chirurgia, University of Bologna,